BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24650966)

  • 21. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts.
    Al-Haddad M; DeWitt J; Sherman S; Schmidt CM; LeBlanc JK; McHenry L; Coté G; El Chafic AH; Luz L; Stuart JS; Johnson CS; Klochan C; Imperiale TF
    Gastrointest Endosc; 2014 Jan; 79(1):79-87. PubMed ID: 23845445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
    Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
    Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature.
    Paal E; Thompson LD; Przygodzki RM; Bratthauer GL; Heffess CS
    Mod Pathol; 1999 May; 12(5):518-28. PubMed ID: 10349991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
    Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
    Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
    Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct localisation of molecules in tissue sections of growing antler tips using MALDI imaging.
    Deb-Choudhury S; Wang W; Clerens S; McMahon C; Dyer JM; Li C
    Mol Cell Biochem; 2015 Nov; 409(1-2):225-41. PubMed ID: 26260050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
    Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
    Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.
    Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Kanemitsu Y; Sano T; Senda Y; Bhatia V; Yanagisawa A
    Pancreas; 2015 Apr; 44(3):459-64. PubMed ID: 25423557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.
    Le Faouder J; Laouirem S; Alexandrov T; Ben-Harzallah S; Léger T; Albuquerque M; Bedossa P; Paradis V
    Proteomics; 2014 Apr; 14(7-8):965-72. PubMed ID: 24678008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
    Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
    Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
    Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
    Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia.
    Emerson RE; Randolph ML; Cramer HM
    Diagn Cytopathol; 2006 Jul; 34(7):457-62. PubMed ID: 16783773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
    Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
    JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms.
    Smith LA; Mckay CJ
    Minerva Med; 2014 Oct; 105(5):413-21. PubMed ID: 25000220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
    Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
    J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic Neoplasms of the Pancreas.
    Chandwani R; Allen PJ
    Annu Rev Med; 2016; 67():45-57. PubMed ID: 26565675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.